Celgene Risk Management

Celgene International Sàrl, a subsidiary of Celgene Corporation CELG, today announced that data from a phase I study of oral, epigenetic therapy CC-486 (oral azacitidine) in patients with lower-risk ...

Dark Reading: A Critical Look at the State Department's Risk Management Profile

Celgene Risk Management 2

The recently unveiled "Risk Management Profile for Artificial Intelligence and Human Rights" by the US Department of State positions itself as a timely and essential framework addressing the growing ...

Business Wire: Ostrich Cyber-Risk Implements the Cyber Risk Institute Cyber Profile to Enhance Risk Management and Cyber Resiliency for Financial Institutions

SALT LAKE CITY--(BUSINESS WIRE)--Ostrich Cyber-Risk, a leading vendor in cyber-risk management offering both qualitative and quantitative solutions, today announced it has joined the Cyber Risk ...

Ostrich Cyber-Risk Implements the Cyber Risk Institute Cyber Profile to Enhance Risk Management and Cyber Resiliency for Financial Institutions

Discover how to create a Risk Profile Summary for effective risk management and download a free ERM tool to streamline the process.

Disaster risk profiles are critical tools that help leaders and disaster risk practitioners make informed decisions on managing disaster risk. National-level disaster risk profiles provide information ...

ascopubs.org: International Myeloma Society/International Myeloma Working Group Consensus Recommendations on the Definition of High-Risk Multiple Myeloma

Celgene Risk Management 9

The current identification of high-risk MM (HRMM) in routine practice is based on the Revised International Staging System, which stratifies patients using a combination of widely available serum ...

Celgene Risk Management 10

International Myeloma Society/International Myeloma Working Group Consensus Recommendations on the Definition of High-Risk Multiple Myeloma

Celgene Risk Management 11

LONDON, May 31 (Reuters) - European regulators have recommended approval of a new drug from Celgene for patients with multiple myeloma whose disease has worsened after being treated with other cancer ...

Celgene Risk Management 12